vs

Side-by-side financial comparison of DHT Holdings, Inc. (DHT) and TREACE MEDICAL CONCEPTS, INC. (TMCI). Click either name above to swap in a different company.

DHT Holdings, Inc. is the larger business by last-quarter revenue ($107.3M vs $62.5M, roughly 1.7× TREACE MEDICAL CONCEPTS, INC.). DHT Holdings, Inc. runs the higher net margin — 41.7% vs -15.0%, a 56.8% gap on every dollar of revenue. On growth, TREACE MEDICAL CONCEPTS, INC. posted the faster year-over-year revenue change (-9.0% vs -24.5%).

DHT Holdings, Inc. is an independent international crude oil tanker operator that owns and manages a fleet of very large crude carriers. It offers marine transportation services for crude oil across major global trade routes, serving clients including leading oil producers, refineries, and commodity trading enterprises worldwide.

Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.

DHT vs TMCI — Head-to-Head

Bigger by revenue
DHT
DHT
1.7× larger
DHT
$107.3M
$62.5M
TMCI
Growing faster (revenue YoY)
TMCI
TMCI
+15.5% gap
TMCI
-9.0%
-24.5%
DHT
Higher net margin
DHT
DHT
56.8% more per $
DHT
41.7%
-15.0%
TMCI

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
DHT
DHT
TMCI
TMCI
Revenue
$107.3M
$62.5M
Net Profit
$44.8M
$-9.4M
Gross Margin
80.6%
Operating Margin
44.2%
-9.5%
Net Margin
41.7%
-15.0%
Revenue YoY
-24.5%
-9.0%
Net Profit YoY
27.3%
-1775.0%
EPS (diluted)
$0.28
$-0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DHT
DHT
TMCI
TMCI
Q4 25
$62.5M
Q3 25
$107.3M
$50.2M
Q2 25
$47.4M
Q1 25
$52.6M
Q4 24
$68.7M
Q3 24
$142.1M
$45.1M
Q2 24
$44.5M
Q1 24
$51.1M
Net Profit
DHT
DHT
TMCI
TMCI
Q4 25
$-9.4M
Q3 25
$44.8M
$-16.3M
Q2 25
$-17.4M
Q1 25
$-15.9M
Q4 24
$-501.0K
Q3 24
$35.2M
$-15.4M
Q2 24
$-21.2M
Q1 24
$-18.7M
Gross Margin
DHT
DHT
TMCI
TMCI
Q4 25
80.6%
Q3 25
79.1%
Q2 25
79.7%
Q1 25
79.7%
Q4 24
80.7%
Q3 24
80.1%
Q2 24
80.2%
Q1 24
80.2%
Operating Margin
DHT
DHT
TMCI
TMCI
Q4 25
-9.5%
Q3 25
44.2%
-31.2%
Q2 25
-35.8%
Q1 25
-29.6%
Q4 24
-0.3%
Q3 24
29.7%
-33.6%
Q2 24
-48.1%
Q1 24
-37.1%
Net Margin
DHT
DHT
TMCI
TMCI
Q4 25
-15.0%
Q3 25
41.7%
-32.4%
Q2 25
-36.7%
Q1 25
-30.3%
Q4 24
-0.7%
Q3 24
24.8%
-34.1%
Q2 24
-47.7%
Q1 24
-36.5%
EPS (diluted)
DHT
DHT
TMCI
TMCI
Q4 25
$-0.14
Q3 25
$0.28
$-0.26
Q2 25
$-0.28
Q1 25
$-0.25
Q4 24
$-0.01
Q3 24
$0.22
$-0.25
Q2 24
$-0.34
Q1 24
$-0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DHT
DHT
TMCI
TMCI
Cash + ST InvestmentsLiquidity on hand
$81.3M
$48.4M
Total DebtLower is stronger
$55.6M
Stockholders' EquityBook value
$1.1B
$87.3M
Total Assets
$1.4B
$190.6M
Debt / EquityLower = less leverage
0.64×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DHT
DHT
TMCI
TMCI
Q4 25
$48.4M
Q3 25
$81.3M
$57.4M
Q2 25
$69.3M
Q1 25
$76.1M
Q4 24
$75.7M
Q3 24
$73.8M
$82.8M
Q2 24
$95.0M
Q1 24
$110.0M
Total Debt
DHT
DHT
TMCI
TMCI
Q4 25
$55.6M
Q3 25
$53.5M
Q2 25
$53.5M
Q1 25
$53.4M
Q4 24
$53.3M
Q3 24
$53.2M
Q2 24
$53.2M
Q1 24
$53.1M
Stockholders' Equity
DHT
DHT
TMCI
TMCI
Q4 25
$87.3M
Q3 25
$1.1B
$89.2M
Q2 25
$97.6M
Q1 25
$105.3M
Q4 24
$112.9M
Q3 24
$1.0B
$104.9M
Q2 24
$112.1M
Q1 24
$126.4M
Total Assets
DHT
DHT
TMCI
TMCI
Q4 25
$190.6M
Q3 25
$1.4B
$196.6M
Q2 25
$206.4M
Q1 25
$205.8M
Q4 24
$217.1M
Q3 24
$1.5B
$212.9M
Q2 24
$226.1M
Q1 24
$242.7M
Debt / Equity
DHT
DHT
TMCI
TMCI
Q4 25
0.64×
Q3 25
0.60×
Q2 25
0.55×
Q1 25
0.51×
Q4 24
0.47×
Q3 24
0.51×
Q2 24
0.47×
Q1 24
0.42×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DHT
DHT
TMCI
TMCI
Operating Cash FlowLast quarter
$60.9M
$-8.0M
Free Cash FlowOCF − Capex
$-10.4M
FCF MarginFCF / Revenue
-16.7%
Capex IntensityCapex / Revenue
3.8%
Cash ConversionOCF / Net Profit
1.36×
TTM Free Cash FlowTrailing 4 quarters
$-29.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DHT
DHT
TMCI
TMCI
Q4 25
$-8.0M
Q3 25
$60.9M
$-9.1M
Q2 25
$-3.0M
Q1 25
$4.2M
Q4 24
$-4.2M
Q3 24
$80.1M
$-11.8M
Q2 24
$-13.9M
Q1 24
$-7.2M
Free Cash Flow
DHT
DHT
TMCI
TMCI
Q4 25
$-10.4M
Q3 25
$-11.9M
Q2 25
$-7.8M
Q1 25
$655.0K
Q4 24
$-7.3M
Q3 24
$-14.7M
Q2 24
$-15.6M
Q1 24
$-11.1M
FCF Margin
DHT
DHT
TMCI
TMCI
Q4 25
-16.7%
Q3 25
-23.7%
Q2 25
-16.5%
Q1 25
1.2%
Q4 24
-10.6%
Q3 24
-32.6%
Q2 24
-35.2%
Q1 24
-21.8%
Capex Intensity
DHT
DHT
TMCI
TMCI
Q4 25
3.8%
Q3 25
5.6%
Q2 25
10.1%
Q1 25
6.7%
Q4 24
4.5%
Q3 24
6.4%
Q2 24
3.9%
Q1 24
7.7%
Cash Conversion
DHT
DHT
TMCI
TMCI
Q4 25
Q3 25
1.36×
Q2 25
Q1 25
Q4 24
Q3 24
2.28×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons